BlackRock Health Sciences Trust (NYSE:BME) Share Price Breaks Below Fifty Day Moving Average – Should You Sell?

BlackRock Health Sciences Trust (NYSE:BME)’s stock price crossed below its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $44.70 and traded as low as $43.71. BlackRock Health Sciences Trust shares last traded at $44.26, with a volume of 33,664 shares traded.

BlackRock Health Sciences Trust Stock Up 0.3%

The firm’s fifty day moving average is $44.74 and its 200-day moving average is $42.29.

BlackRock Health Sciences Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, December 22nd. Shareholders of record on Friday, December 11th will be issued a dividend of $0.2621 per share. This represents a $3.15 annualized dividend and a yield of 6.9%. The ex-dividend date of this dividend is Friday, December 11th.

Institutional Investors Weigh In On BlackRock Health Sciences Trust

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Bank of America Corp DE bought a new stake in BlackRock Health Sciences Trust in the second quarter valued at about $11,827,000. Cypress Capital Management LLC WY raised its stake in BlackRock Health Sciences Trust by 18.8% during the second quarter. Cypress Capital Management LLC WY now owns 53,307 shares of the company’s stock valued at $2,290,000 after buying an additional 8,447 shares in the last quarter. Wealthspire Retirement LLC raised its stake in BlackRock Health Sciences Trust by 12.2% during the first quarter. Wealthspire Retirement LLC now owns 51,887 shares of the company’s stock valued at $1,998,000 after buying an additional 5,635 shares in the last quarter. First Trust Advisors LP raised its stake in BlackRock Health Sciences Trust by 16.5% during the first quarter. First Trust Advisors LP now owns 26,507 shares of the company’s stock valued at $1,021,000 after buying an additional 3,745 shares in the last quarter. Finally, NewEdge Advisors LLC raised its stake in BlackRock Health Sciences Trust by 22.9% during the second quarter. NewEdge Advisors LLC now owns 15,143 shares of the company’s stock valued at $650,000 after buying an additional 2,817 shares in the last quarter.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE:BME) is a closed-end investment company that seeks to provide investors with total return through a combination of current income and long-term capital appreciation. The trust is managed by BlackRock Advisors, LLC, part of BlackRock, Inc, a global investment management firm.

The trust invests primarily in equity securities of companies involved in the health sciences sector. Its investment universe may include pharmaceutical, biotechnology, medical device, health care services, life sciences tools and diagnostics, and related businesses.